The company’s revolutionary treatment and recovery program, using the product Ibogaine, will initially focus on the opioid epidemic in British Columbia followed by North America.
source
OCT
2018
Posted by:
The company’s revolutionary treatment and recovery program, using the product Ibogaine, will initially focus on the opioid epidemic in British Columbia followed by North America.
source
The African psychoactive alkaloid Ibogaine, Schedule 1 in the USA, researched for substance use since the 1950’s, has demonstrated effectiveness in reversing tolerance & craving for opioids, stimulants & alcohol. Risks & fatalities are involved, due to the demographic, screening, inducing bradycardia, prolonging the QT interval & blocking the Potassium hERG channel, further complicated by opioid maintenance medications & psychiatric drugs. Almost all ibogaine centres, rapidly increasing ...